Dry Eye Awareness

>

Latest News

BostonSight publishes pilot study on PROSE scleral lenses as a drug delivery system for cyclosporine in dry eye treatment
BostonSight publishes pilot study on PROSE scleral lenses as a drug delivery system for cyclosporine in dry eye treatment

December 6th 2024

BostonSight’s pilot study, published in Clinical Ophthalmology, explores the use of PROSE scleral lenses as a drug delivery system for cyclosporine 0.05% in treating dry eye disease, showing promising symptom relief and tolerability.

Sun Pharma announces positive Phase 4 data results in dry eye disease
Sun Pharma announces positive Phase 4 data results in dry eye disease

November 14th 2024

Harrow announces expanded market access for cyclosporine ophthalmic solution in 2025 Medicare Part D Program
Harrow announces expanded market access for cyclosporine ophthalmic solution in 2025 Medicare Part D Program

November 12th 2024

Intense pulsed light for treatment of dry eye disease
Intense pulsed light for treatment of dry eye disease

October 31st 2024

Bausch + Lomb dry eye survey shows that many sufferers don’t understand the severity of the disease
Bausch + Lomb dry eye survey shows that many sufferers don’t understand the severity of the disease

July 8th 2024

Video Series

More News

© 2024 MJH Life Sciences

All rights reserved.